tiprankstipranks

Dimerix Corrects Director Interest Notice

Story Highlights
Dimerix Corrects Director Interest Notice

Confident Investing Starts Here:

An update from Dimerix Limited ( (AU:DXB) ) is now available.

Dimerix Limited has announced a correction to the Change of Director’s Interest Notice, revealing that Managing Director Nina Webster acquired 127,917 ordinary shares through the exercise of options. This correction ensures transparency in the company’s disclosures, potentially affecting stakeholder trust and market perceptions.

More about Dimerix Limited

Dimerix is a biopharmaceutical company focused on developing innovative therapies to address unmet medical needs.

YTD Price Performance: 27.94%

Average Trading Volume: 2,341,072

Technical Sentiment Consensus Rating: Strong Sell

Current Market Cap: A$242.9M

For an in-depth examination of DXB stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App